EPCAM and cancer: Importantly, in analogous experiments using PC3M.EpCAM-KO cells, EpCAM-ReTARGTPRvIL2 induced a similar increase in cancer cell lysis of ~15%, suggesting that EpCAM-ReTARGTPRvIL2 enhances cancer cell lysis irrespective of EpCAM expression.